8-K: Goldenwell Biotech Changes Auditors, Appoints Yusufali & Associates

Goldenwell Biotech has dismissed BF Borgers CPA PC as its independent auditor and appointed Yusufali & Associates, LLC, effective May 15, 2024.

Summary

• Goldenwell Biotech, Inc. dismissed BF Borgers CPA PC as their independent registered public accounting firm on May 14, 2024.
• The dismissal was recommended and approved by the company's Board of Directors.
• BF Borgers' reports on the company's financial statements for 2023 and 2022 did not contain any adverse opinions or disclaimers, but did express substantial doubt about the company's ability to continue as a going concern.
• There were no disagreements between Goldenwell Biotech and BF Borgers on accounting principles, financial statement disclosure, or auditing scope.
• On May 15, 2024, Goldenwell Biotech appointed Yusufali & Associates, LLC as their new independent registered public accountants.
• The company did not consult with Yusufali & Associates on any matters that were the subject of disagreement with the previous auditor.

Sentiment

Score: 3

Explanation: The change in auditors combined with the going concern warning from the previous auditor creates a negative sentiment. While the transition was smooth, the underlying financial concerns are significant.

Positives

• The transition to a new auditor was completed quickly and without any reported disagreements on accounting or auditing matters.

Negatives

• The previous auditor, BF Borgers, expressed substantial doubt about Goldenwell Biotech's ability to continue as a going concern.

Risks

• The change in auditors could raise concerns among investors about the company's financial health.
• The going concern warning from the previous auditor indicates potential financial instability.

Management Comments

• The Board of Directors recommended and approved the dismissal of BF Borgers.
• The Board of Directors resolved to engage Yusufali & Associates as the new independent registered public accountants.

Industry Context

Changes in auditors are not uncommon, but the going concern warning from the previous auditor may raise concerns within the biotech industry, which is often scrutinized for financial stability.

Comparison to Industry Standards

• The change of auditors is not unusual, but the going concern warning is a significant issue that is not typical for established companies.
• Many biotech companies use large, well-known accounting firms, so the switch to Yusufali & Associates, a smaller firm, may be viewed with caution by some investors.

Stakeholder Impact

• Shareholders may be concerned about the company's financial stability due to the going concern warning.
• Employees may be concerned about the company's long-term viability.
• Creditors may be more cautious about extending credit to the company.

Key Dates

Keywords

auditor, accounting, BF Borgers, Yusufali & Associates, going concern, financial statements, audit